Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Imago BioSciences, Inc. (IMGO : NSDQ)
 
 • Company Description   
Imago BioSciences Inc. is a clinical stage biopharmaceutical company. It involved in discovering new medicines for the treatment of myeloproliferative neoplasms. Imago BioSciences Inc. is based in SOUTH SAN FRANCISCO, Calif.

Number of Employees: 27

 
 • Price / Volume Information   
Yesterday's Closing Price: $15.12 Daily Weekly Monthly
20 Day Moving Average: 190,391 shares
Shares Outstanding: 33.74 (millions)
Market Capitalization: $510.09 (millions)
Beta:
52 Week High: $35.68
52 Week Low: $12.85
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -14.58% -6.40%
12 Week -31.15% -25.29%
Year To Date -36.23% -24.17%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
329 Oyster Point Blvd. 3rd Floor
-
South San Francisco,CA 94080
USA
ph: 415-529-5055
fax: -
laurence@gilmartinir.com http://www.imagobio.com
 
 • General Corporate Information   
Officers
Hugh Y. Rienhoff - Chief Executive Officer; Director
Dennis Henner - Chairman and Director
Laura G. Eichorn - Chief Financial Officer
Patrick Heron - Director
Robert Baltera - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 45250K107
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/18/22
Share - Related Items
Shares Outstanding: 33.74
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $510.09 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.44 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.79 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/18/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.55
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -11.36%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -36.94
12/31/21 - -59.66
09/30/21 - -66,601.30
ROA
03/31/22 - -27.17
12/31/21 - -26.42
09/30/21 - -25.75
Current Ratio
03/31/22 - 16.16
12/31/21 - 21.93
09/30/21 - 26.33
Quick Ratio
03/31/22 - 16.16
12/31/21 - 21.93
09/30/21 - 26.33
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 5.91
12/31/21 - 6.40
09/30/21 - 6.83
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©